Oral fluoropyrimidines in the treatment of colorectal cancer.
Bissett
D
D
Department of Clinical Oncology, Grampian University Hospitals and University of Aberdeen, UK. med105@abdn.ac.uk
Ahmed
F
F
McLeod
H
H
Cassidy
J
J
D000284:Administration, Oral; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000008:administration & dosage; D015179:Colorectal Neoplasms / Q000188:drug therapy* / Q000473:pathology; D005472:Fluorouracil / Q000378:metabolism / Q000627:therapeutic use; D006801:Humans; D011743:Pyrimidines / Q000493:pharmacokinetics / Q000494:pharmacology / Q000627:therapeutic use*; D005641:Tegafur / Q000008:administration & dosage; D014498:Uracil / Q000008:administration & dosage
D011743:Pyrimidines; D005641:Tegafur; D014498:Uracil; D005472:Fluorouracil